Clinical Trials Logo

Clinical Trial Summary

Chronic alcohol ingestion is related with leaky gut syndrome. Colostrum is well-studied that it has a effect of decreasing the degree of leaky gut syndrome.

So the investigators are planning to find out whether Colostrum has a effect of decreasing the degree of leaky gut syndrome.


Clinical Trial Description

We randomly sort the participant as placebo group and colostrum group. Each group consists of 17 people. and the duration of our study for one participant is 3 weeks. (Participant takes colostrum for 3 weeks.)

When a person gets leaky gut syndrome, his or her endotoxin and lactulose/mannitol ratio (L/M ratio, in urine) can elevate.

So We will compare the value of those two parameters and LFT. etc. after the administration of colostrum or placebo. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01088087
Study type Interventional
Source Gangnam Severance Hospital
Contact Jae Yong Shim, Master
Phone 82-02-2019-3155
Email hongbai96@yuhs.ac.kr
Status Recruiting
Phase Phase 2/Phase 3
Start date March 2010
Completion date December 2010

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04067440 - Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
Recruiting NCT05602116 - ASC - Autism Study Phase 1